Viewing Study NCT06296602


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-02-20 @ 12:35 PM
Study NCT ID: NCT06296602
Status: RECRUITING
Last Update Posted: 2024-03-08
First Post: 2024-02-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Screening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV (ANAPreP'HPV)
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Overview

Official Title: Screening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ANAPreP'HPV
Brief Summary: This is an interventional study investigating HPV carriage and liquid-based cytology at anal level. It will be offered to all patients undergoing PreP consultations at Besançon University Hospital. The anal swab will be taken by the doctor using a cyto-brush during the consultation.
Detailed Description: The duration of participation in the study is 3 months for the submission of the results of the samples. A medical proctology consultation may also be offered, depending on the results of the screening.

This will be carried out in addition to the anal swabs taken quarterly to screen for other sexually transmitted infections.

A questionnaire will be completed by the doctor to record the data of interest. From additional data already entered in the e-NADIS software will be included for study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: